AcuCort today announces that the nomination committee for the 2026 annual general meeting has been appointed and consists of representatives of the company’s three largest shareholders.
After consultation with the company’s largest shareholders in terms of votes, as of September 30 2025, the nomination committee consists of the following members:
- Sarah Fredriksson, Aqilion AB, Chair of the nomination committee
- Anne-Charlotte Poulsen, Life Science Investment Fund (LSIF)
- Tomas Nilsson, representing Jonas Jönmark, CEO of AcuCort
The 2026 Annual General Meeting will be held in Lund. The exact date will be announced in the notice convening the meeting. The Nomination Committee’s proposals will be presented in the notice and on the company’s website.